Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Track record
Movers
The Lead Compound
Home
›
Targets
› ICP34.5
ICP34.5
(1 companies · 1 programs)
Companies with an active program directed at ICP34.5.
Candel Therapeutics, Inc.
CADL
linoserpaturev
— Recurrent High-Grade Glioma
Phase 1